# Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection

> **NCT00163657** · PHASE4 · COMPLETED · sponsor: **Baylor Research Institute** · enrollment: 312 (actual)

## Conditions studied

- End Stage Liver Disease
- Hepatitis C

## Interventions

- **DRUG:** Daclizumub
- **DRUG:** Tacrolimus
- **DRUG:** Cyclosporine
- **DRUG:** MMF

## Key facts

- **NCT ID:** NCT00163657
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2006-04
- **Final completion:** 2007-01
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2017-01-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163657, "Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00163657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*